Chief Editors and Future Plans of Oncotarget

Since its inception in 2010, Onoctarget has had several goals which are to provide their large reader base with accurate information and data, help spread the knowledge of latest medical and biological research, as well as to have their issues submitted to PubMed as soon as they go live online.

Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/

The biomedical journal has been working towards accomplishing that goal, and after their 35th and 36th issues have been processed by the National Library of Medicine, they will be added to PubMed. That is a milestone for Oncotarget. Another milestone for the online journal is its d publication schedule. Oncotarget has been publishing once every week e its started in 2010. At the start of 2018, the Oncotarget journal started putting out issues two times a week in order o provide more information about current medical and biological research to its readers. So far, Oncotarget has accomplished seven volumes and s working on its eight one. There is a total of 324 issues as of December 2017. Check the journal at SCImago Journal & Country Rank.

Oncotarget can be accessed by the general public and not only medical experts and practitioners. in order to provide reader base with as accurate an information as possible, Oncotarget is also peer-reviewed. The journal has a hugely extensive editorial board. As it published research in several areas of research, Oncotarget has an advisory board for each discipline such as Immunology, Pathology, Chromosomes, Aging, Autophagy, and more.

Oncotarget has two doctors working as Editor in Chief. Dr. Andrei V. Gudjkov has been working at the Roswell Park Cancer Institute (RPCI) for more than a decade. He is also a Professor and Garman Family Chair in Cell Stress Biology as well as a Senior Vice President for Basic Research at the RPCI. Andrei V. Gudkov, Ph. D. as achieved a degree in molecular biology and experimental oncology. Gudkov co-founded the Cleveland Biolabs, Inc as well as Taris Inc.

Dr, Mikhail Blagosklonny used to work t RPCI as well up until 2016. He graduated from the Russian First Pavlov State University in cardiology and oncology. Dr, Mikhail Blagosklonny has made a substantial contribution through his articles and papers. He is Associate Editors of journals such as Cell Cycle, Cell Death Differ, Cancer Res, and more. Learn more about Oncotarget at Eurekalert.org.

The Dedicated And Passionate James Dondero

James Dondero is an important figure in the Dallas, Texas area. He is a hedge fund manager, entrepreneur, and well-known philanthropist. But what else is there to know about James Dondero?

With a career spanning over 30 years, Dondero started as an analyst in 1984. That year, he entered the Morgan Guaranty training program and also became a graduate of the University of Virginia’s McIntire School of Commerce with dual majors to show for his hard work. In the years to come, he earned both his CMA and CFA certifications.

Most of Dondero’s experience is in credit and equity management.

After graduating from the University of Virginia, James Dondero worked for the prestigious company American Express from 1985 to 1989. Even though he started at American Express as a bond analyst for corporations, he was eventually promoted to a portfolio manager. After he left American Express, he worked for Protective Life as a Chief Investment Officer and the business thrived in Dondero’s presence.

James Dondero co-founded Highland Capital Management in 1993.

Highland Capital Management, L.P. is an award-winning network of investment advisors. With assets totaling over $14 billion, the Dallas-based business specializes in creating unique investment opportunities for its diverse variety of clients.

Besides being President and co-founder of Highland Capital Management, Dondero is a prominent philanthropist in the Dallas, Texas area. He has granted money to The Dallas Zoo, The Family Place, Education is Freedom and more. James Dondero also sits as a member on boards for MGM and American Banknote.

Whitney Wolfe as an Entrepreneur Decides Her Own Life

     Whitney Wolfe has worked many different jobs. Then she has discovered the advantages of being an entrepreneur. When she has decided on being an entrepreneur, she realized that she can actually create the type of job she wants in any industry. This has brought forth the opportunity of creating an online dating app. However, she also knew that there is a need for something different. Otherwise, she is not going to be very successful at attracting the customers she needs in order for her app to be a success. Therefore, she looked at what she could provide that the other apps don’t provide.

One of the ways that Whitney Wolfe has figured out what she can offer is by looking at the other dating apps that are on the market. As she has looked at the apps, she has gotten ideas. For one thing, she has seen that the balance of online dating has been skewed towards the women. In other words, women often had their message inbox while men were empty. In many cases, men have gone around sending messages in order to see what they can get. One thing that happens a lot is that men are on message boards talking about how hard it is to get a date with dating apps. This is where Whitney Wolfe came up with the idea for Bumble.

Whitney has decided that she wanted to try something different with dating apps. She has looked into different ways to configure the app. She has finally decided that she can prevent men from messaging women. Instead, women are going to have to make the first move. This is actually a dream come true for men that don’t like to initiate. This also encourages women to go after what they want in their lives.

For more, please check https://www.ft.com/content/58c69c92-08b6-11e7-97d1-5e720a26771b.

About Us

Looking for information on weddings, dating, relationships and other similar topics? This is the place for you. Many girls, and even guys, like to get into these topics online to learn more. Thanks for visiting!